Faouzi Djebbari
21PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (21)
Sort by Publication Date:
|Jan 31, 2023
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.Faouzi Djebbari, Alexandros Rampotas, Grant Vallance
|Jun 06, 2022
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study.Faouzi Djebbari, Alexandros Rampotas, Grant Vallance
|May 28, 2022
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events.Edmund Watson, Faouzi Djebbari, Alexandros Rampotas
|Feb 08, 2022
Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series.Faouzi Djebbari, Matt Poynton, Gina Sangha
|Jan 11, 2022
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas
|Jan 26, 2021
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.Alexandros Rampotas, Faouzi Djebbari, Fotios Panitsas
Pageof 4
Frequent Collaborators
4 joint publications
Toby A Eyre
3 joint publications
Fotios Panitsas
3 joint publications
Karthik Ramasamy
2 joint publications
John Willan
2 joint publications
Alexandros Rampotas
1 joint publications
Akhil Khera
1 joint publications
Grant Vallance
1 joint publications
Sue Pavord
1 joint publications
Faye A Sharpley
1 joint publications
Firas Al-Kaisi
